These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36029297)

  • 1. The Urgent Need for FDA to Approve a Whole-Body Application of Ultrasound Contrast Agents.
    Barr RG
    J Ultrasound Med; 2023 Apr; 42(4):761-764. PubMed ID: 36029297
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric contrast-enhanced ultrasound: shedding light on the pursuit of approval in the United States.
    Darge K; Back SJ; Bulas DI; Feinstein SB; Ntoulia A; Volberg FM; Wilson SR; McCarville MB
    Pediatr Radiol; 2021 Nov; 51(12):2128-2138. PubMed ID: 34117520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-label use of ultrasound contrast agents for abdominal imaging in the United States.
    Barr RG
    J Ultrasound Med; 2013 Jan; 32(1):7-12. PubMed ID: 23269705
    [No Abstract]   [Full Text] [Related]  

  • 4. Product safety compromises patient safety (an unjustified black box warning on ultrasound contrast agents by the Food and Drug Administration).
    Grayburn PA
    Am J Cardiol; 2008 Mar; 101(6):892-3. PubMed ID: 18328861
    [No Abstract]   [Full Text] [Related]  

  • 5. How to set up a contrast-enhanced ultrasound service.
    Weinstein S; Jordan E; Goldstein R; Yee J; Morgan T
    Abdom Radiol (NY); 2018 Apr; 43(4):808-818. PubMed ID: 28779334
    [No Abstract]   [Full Text] [Related]  

  • 6. Contrast-enhanced ultrasound of benign liver lesions.
    Zarzour JG; Porter KK; Tchelepi H; Robbin ML
    Abdom Radiol (NY); 2018 Apr; 43(4):848-860. PubMed ID: 29167944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric contrast-enhanced ultrasound in the United States: a survey by the Contrast-Enhanced Ultrasound Task Force of the Society for Pediatric Radiology.
    Back SJ; Maya C; Darge K; Acharya PT; Barnewolt CE; Coleman JL; Dillman JR; Fordham LA; Hwang M; Lim A; McCarville MB; Munden MM; Paltiel HJ; Volberg FM
    Pediatr Radiol; 2018 Jun; 48(6):852-857. PubMed ID: 29442152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the 2008 Food and Drug Administration Advisory Committee on safety considerations in the development of ultrasound contrast agents.
    Asch FM; Weissman NJ
    Circulation; 2009 Apr; 119(14):1956-61. PubMed ID: 19364988
    [No Abstract]   [Full Text] [Related]  

  • 9. The FDA does not approve uses of drugs.
    Archer JD
    JAMA; 1984 Aug 24-31; 252(8):1054-5. PubMed ID: 6748212
    [No Abstract]   [Full Text] [Related]  

  • 10. Bubble trouble?
    ter Haar G
    Ultraschall Med; 2008 Oct; 29(5):550-1. PubMed ID: 18937172
    [No Abstract]   [Full Text] [Related]  

  • 11. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines.
    Barreiros AP; Piscaglia F; Dietrich CF
    J Hepatol; 2012 Oct; 57(4):930-2. PubMed ID: 22739095
    [No Abstract]   [Full Text] [Related]  

  • 12. If Kindness Were a Drug, the FDA Would Approve It.
    Asch SM; Atkins DV; Walling A
    J Gen Intern Med; 2021 Feb; 36(2):263-264. PubMed ID: 33245513
    [No Abstract]   [Full Text] [Related]  

  • 13. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
    Seitz K; Strobel D
    Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who would approve new drugs if there were no FDA?
    Gatty B
    Hosp Formul; 1995 Jan; 30(1):58, 57. PubMed ID: 10139726
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA approve bark-derived drug.
    Barnett AA
    Lancet; 1996 Jun; 347(9015):1613. PubMed ID: 8667876
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug development in inflammatory bowel disease: the role of the FDA.
    Lahiff C; Kane S; Moss AC
    Inflamm Bowel Dis; 2011 Dec; 17(12):2585-93. PubMed ID: 21484967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International recommendations and guidelines for the safe use of diagnostic ultrasound in medicine.
    Barnett SB; Ter Haar GR; Ziskin MC; Rott HD; Duck FA; Maeda K
    Ultrasound Med Biol; 2000 Mar; 26(3):355-66. PubMed ID: 10773365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delegations of authority and organization; Center for Drug Evaluation and Research--FDA. Final rule.
    Fed Regist; 1993 Apr; 58(61):17093-4. PubMed ID: 10125229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA panel finds insufficient data to approve antimicrobial glove.
    AIDS Patient Care STDS; 1996 Oct; 10(5):316. PubMed ID: 11361539
    [No Abstract]   [Full Text] [Related]  

  • 20. EMA and FDA decisions based on flawed evidence to approve new cancer drugs negatively affect Latin American patients.
    Durán CE; Cañás M; Chistiaens T
    BMJ; 2019 Oct; 367():l6017. PubMed ID: 31615783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.